Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
A Key Regulator of Dendritic Morphology in Supragranular Neocortex Impacts Mismatch Negativity.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
MAP2 phosphorylation: mechanisms, functional consequences, and emerging insights.
Journal: Frontiers in cellular neuroscience
Published: April 11, 2025
Oligodendrocyte myelin glycoprotein impairs dendritic arbors via schizophrenia risk gene Trio.
Journal: Neurobiology of disease
Published: January 10, 2025
Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation.
Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation.
Journal: Neurobiology of disease
Published: March 11, 2024
RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice.
Journal: Research square
Published: February 07, 2023
Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.
Journal: Nature communications
Published: January 26, 2023
Editorial: Molecular mechanisms of neuropsychiatric diseases.
Journal: Frontiers in molecular neuroscience
Published: November 18, 2022
Trio and Kalirin as unique enactors of Rho/Rac spatiotemporal precision.
Journal: Cellular signalling
Published: June 22, 2022
More than a marker: potential pathogenic functions of MAP2.
Journal: Frontiers in molecular neuroscience
Published: June 21, 2022
A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 15, 2021
Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research.
Journal: Frontiers in molecular neuroscience
Published: April 01, 2021
MAP2 is differentially phosphorylated in schizophrenia, altering its function.
Journal: Molecular psychiatry
Published: April 16, 2020
Last Updated: 09/26/2026